Such a pleasure working with this young lady. Great work Abby!

Never been to a meeting with such a fun opening! Patriotic colonial band in Philly- fun surprise to start the morning #evs2022

On World Thrombosis Day, we continue our dedication to educating patients and caregivers on the risk factors, warning signs, and prevention tips for blood clots, DVT, and pulmonary embolisms as part of our commitment to improving lives affected by one of the most deadly diseases.

Attending the health equity and cardiology prn sessions at @accpgc22. Both sessions were good, but also entertaining! Had great laughs in both sessions. Thanks for keeping it interesting and informative!

Great and important work Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP

New HFpEF 2023 ACC Expert Consensus Doc. Curious to know what everyone's opinion of MRAs being on the same level of rec as ARNIs and ARBs ACCP Cardiology PRN jacc.org/doi/10.1016/j.…

Join us for our NAPLEX Twitter Takeover this May!

Which mechanism of action for antiarrhythmics has a greater potential for inducing Torsades de Pointes? #NAPLEXTwitterTakeover

💊🫀🏥 How do you utilize SGLT2 inhibitors in hospitalized HF patients? Please share your comments/pearls in the comments section so we can learn from multiple insights/vantage points!

Happy #ThrowbackThursday! Check out this great review of the OASIS-6 Trial created by @noblerx! #CardioTwitter 🫀 pubmed.ncbi.nlm.nih.gov/21146657/

In our research we found that women were told they were too young to lead, too old to lead...and middle age wasn't quite right either. As it turns out no age is the right age to be a woman leader. See my latest Harvard Business Review article for solutions. hbr.org/2023/06/women-…

Q: Patient is admitted for an anterior STEMI and receives 2 DES to the LAD. Ticagrelor 180 mg is given in the cath lab. PMH: CAD, HFpEF, stroke (hemorrhagic 3 years ago), and hypothyroidism.Which P2Y12 regimen is most appropriate to initiate? #boardprep #BCCP

It's #TeachingTuesday! Jared Anders, PharmD shares with us these helpful infographics on the recently published FREEDOM COVID trial. Does a diagnosis of COVID-19 play a role in your dosing of anticoagulation? 🩸

Answer: B. In the SAVOR cardiovascular outcomes trial, patients treated with saxagliptin were found to have increased hospitalizations for heart failure compared with placebo. Patients with a prior history of HF or renal impairment had a higher risk for HF hospitalization

Need a review on management of HF-related cardiogenic shock? 🏥🫀🏥🫀🏥🫀🏥🫀🏥 This article in JACC HF published July 2023 may do the trick! jacc.org/doi/10.1016/j.…

GDMT for HFrEF ✅ Quadruple, rather than double/triple ✅ Simultaneously, rather than sequentially ✅ Today, rather than someday ✅ Urgently, rather than lackadaisically ✅ Expeditiously, rather than delayed ✅ Now, rather than later ✅ Systematically rather than haphazardly

.Anticoagulation Forum providing important perspective to revised Beers Criteria in Letter to Editor agsjournals.onlinelibrary.wiley.com/doi/full/10.11… Essential that clinicians consider all reasonable therapeutic options for individual patients ➕ shared decision-making Geoff Barnes

Ryan Blosser, PharmD candidate presents a topic today that transcends across almost all cardiology pharmacists. Be sure to check out this SGLT2 and Heart Failure Focused Teaching Tuesday

Join us for our next Cards PRN JC on Sept 26th @ 3PM EST. We’ll be discussing the prevention of chemotherapy-related cardiotoxicity with PGY2 CV residents Dr. Abigail Mathes and Dr. Holly Tyson as they review STOP-CA and CECCY trials! google.com/url?q=https%3A…!

Love this meeting #acc2024 The Super Bowl of Cardiology!